Oaktree Specialty Lending (NASDAQ:OCSL - Get Free Report) released its quarterly earnings data on Tuesday. The credit services provider reported $0.34 EPS for the quarter, missing analysts' consensus estimates of $0.36 by ($0.02), FiscalAI reports. The business had revenue of $69.15 million for the quarter, compared to the consensus estimate of $69.40 million. Oaktree Specialty Lending had a return on equity of 9.56% and a net margin of 16.66%.
Oaktree Specialty Lending Trading Down 0.2%
Shares of NASDAQ:OCSL traded down $0.02 during trading on Wednesday, hitting $12.11. 659,031 shares of the company's stock were exchanged, compared to its average volume of 777,116. The company has a current ratio of 0.17, a quick ratio of 0.17 and a debt-to-equity ratio of 0.68. The firm has a market cap of $1.07 billion, a P/E ratio of 21.25 and a beta of 0.49. The firm has a 50-day moving average price of $11.91 and a two-hundred day moving average price of $11.95. Oaktree Specialty Lending has a 1-year low of $10.63 and a 1-year high of $14.31.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Oaktree Specialty Lending in the 4th quarter valued at $42,000. Tower Research Capital LLC TRC increased its stake in shares of Oaktree Specialty Lending by 1,025.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,163 shares of the credit services provider's stock worth $57,000 after purchasing an additional 3,793 shares during the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of Oaktree Specialty Lending in the 4th quarter valued at about $86,000. BNP Paribas Financial Markets purchased a new position in shares of Oaktree Specialty Lending in the 3rd quarter valued at approximately $97,000. Finally, Captrust Financial Advisors bought a new stake in Oaktree Specialty Lending in the 2nd quarter worth about $149,000. Institutional investors own 36.79% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on OCSL. Weiss Ratings cut shares of Oaktree Specialty Lending from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, July 24th. Oppenheimer set a $13.00 price objective on Oaktree Specialty Lending in a research report on Wednesday, May 6th. Finally, Wall Street Zen raised Oaktree Specialty Lending from a "sell" rating to a "hold" rating in a research note on Saturday. Four investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and a consensus target price of $11.83.
Get Our Latest Analysis on Oaktree Specialty Lending
About Oaktree Specialty Lending
(
Get Free Report)
Oaktree Specialty Lending Corporation NASDAQ: OCSL is a closed-end, externally managed specialty finance company structured as a business development company (BDC). Launched in 2014, Oaktree Specialty Lending provides customized debt solutions to U.S. middle-market companies, with a focus on senior secured loans, second-lien financings, mezzanine debt and select equity co-investments. The company’s investment strategy centers on floating-rate instruments designed to offer downside protection and income potential in varying interest rate environments.
The firm’s portfolio spans a diverse array of industries, including healthcare, technology, energy, business services and consumer products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Oaktree Specialty Lending, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Specialty Lending wasn't on the list.
While Oaktree Specialty Lending currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.